Brent Flickinger, MD
Rheumatology · Gainesville, GANPI 1902914872
Payments from drug & device makers
Across 1,218 payments — averaging $1331.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$1M
- AbbVie$397K
- Amgen$86K
- E.r. Squibb & Sons, L.L.C.$71K
- UCB SA$32K
- Aurinia Pharma U.S., Inc.$17K
- plus $9K from 29 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 117 | $1,009,872 |
| AbbVie | 394 | $396,830 |
| Amgen(2 entities) | 145 | $85,682 |
| E.r. Squibb & Sons, L.L.C. | 65 | $71,288 |
| UCB SA | 5 | $32,306 |
| Aurinia Pharma U.S., Inc. | 35 | $16,955 |
| UCB, Inc. | 116 | $1,882 |
| Johnson & Johnson | 64 | $1,379 |
| Pfizer | 61 | $1,044 |
| AstraZeneca(2 entities) | 35 | $813 |
| Sanofi | 29 | $521 |
| Lilly USA, LLC | 30 | $490 |
| Boehringer Ingelheim | 18 | $454 |
| GSK | 22 | $408 |
| Genentech USA, Inc. | 14 | $268 |
| Radius Health, Inc. | 9 | $203 |
| Organon | 10 | $178 |
| Sobi, Inc | 10 | $166 |
| Bristol Myers Squibb | 7 | $135 |
| Sanofi-aventis U.S. LLC | 2 | $113 |
| Sandoz | 3 | $63 |
| Merck | 4 | $61 |
| Fresenius Kabi USA, LLC | 3 | $59 |
| Actelion Pharmaceuticals US, Inc. | 3 | $51 |
| ANI Pharmaceuticals, Inc. | 2 | $49 |
| Teva Pharmaceuticals USA, Inc. | 3 | $41 |
| Medexus Pharma, Inc. | 3 | $38 |
| Antares Pharma, Inc. | 2 | $32 |
| Boston Scientific | 1 | $31 |
| Scilex Pharmaceuticals Inc. | 1 | $25 |
| Octapharma USA, Inc. | 1 | $25 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $20 |
| Grifols USA, LLC | 1 | $20 |
| Invivyd Inc | 1 | $19 |
| Gilead | 1 | $16 |
How this compares
$1,621,538 in reported general payments places this provider in the 95th percentile of 177 rheumatology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Gainesville
- Marta BognarGainesville$719K
- William ChafinGainesville$18K
- Stephen ElmoreGainesville$18K
- Huma SohailGainesville$14K
- Theresa Lawrence FordLawrenceville$2.9M
- Wambui MachuaAtlanta$1.8M
- James MossellTifton$1.6M
- Roel QuerubinMarietta$1.5M
- Arezou KhosroshahiAtlanta$1.5M
- Sung LimAtlanta$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.